Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR at VERA
- Sold, on record
- $2.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Feb 23, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VERAVera Therapeutics, Inc.SVP, FINANCE, CHIEF ACCT OFFCR
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale VERANo planApr 10, 2024 2024
Sold 5,714 shares at $40.00 ($229k)
Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
No 10b5-1 planSold 9.7% of holdings ($2.4M position)53,171 shares leftFirst sale on recordFiling
- 2 Form 4 sale VERAUnusualMay 16, 2024 +36 days
Sold 30,837 shares at $42.30 ($1.3M)
Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
No 10b5-1 planSold 37.6% of holdings ($3.5M position)51,206 shares leftFiling
- 3 Form 4 sale VERANo planNov 11, 2025 +544 days
Sold 15,000 shares at $29.06 ($436k)
Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
No 10b5-1 planSold 23.9% of holdings ($1.8M position)47,839 shares leftFiling
- 4 Form 4 sale VERANo planFeb 23, 2026 +104 days
Sold 3,117 shares at $41.98 ($131k)
Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
No 10b5-1 planSold 4.6% of holdings ($2.8M position)64,722 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 25, 2026 | VERA | SVP, FINANCE, CHIEF ACCT OFFCR | Form 4 sale | 3,117 | $131k | 4.6% | No plan | SEC |
| Nov 11, 2025 | Nov 13, 2025 | VERA | SVP, FINANCE, CHIEF ACCT OFFCR | Form 4 sale | 15,000 | $436k | 23.9% | No plan | SEC |
| May 16, 2024 | May 17, 2024 | VERA | SVP, FINANCE, CHIEF ACCT OFFCR | Form 4 sale | 30,837 | $1.3M | 37.6% | Unusual | SEC |
| Apr 10, 2024 | Apr 12, 2024 | VERA | SVP, FINANCE, CHIEF ACCT OFFCR | Form 4 sale | 5,714 | $229k | 9.7% | No plan | SEC |